NEOE:VRNOPharmaceuticals
Verano Holdings FY 2025 Loss Of US$183 Million Tests Bullish Margin Narrative
Verano Holdings (NEOE:VRNO) has just posted its FY 2025 numbers, with Q4 revenue of US$206.6 million and a basic EPS loss of US$0.51, alongside a trailing 12 month revenue base of US$821.5 million and a net loss of US$257.9 million. The company has seen quarterly revenue move from US$216.7 million in Q3 2024 to between about US$202 million and US$210 million across 2025, while basic EPS remained in loss making territory each quarter. For investors, the latest print keeps the focus squarely on...